Pages that link to "Q24631837"
Jump to navigation
Jump to search
The following pages link to APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy (Q24631837):
Displaying 50 items.
- The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival (Q24594836) (← links)
- Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease (Q24599916) (← links)
- Systematic reviews of animal models: methodology versus epistemology (Q24629614) (← links)
- FSGS: Diagnosis and Diagnostic Work-Up (Q26744558) (← links)
- Ethnic Differences in Childhood Nephrotic Syndrome (Q26752347) (← links)
- Secondary Focal Segmental Glomerulosclerosis: From Podocyte Injury to Glomerulosclerosis (Q26752830) (← links)
- APOL1 Kidney Disease Risk Variants: An Evolving Landscape (Q26799191) (← links)
- Opportunities and Challenges of Genotyping Patients With Nephrotic Syndrome in the Genomic Era (Q26799197) (← links)
- Insights into the genetic architecture of diabetic nephropathy (Q26823352) (← links)
- Kidney disease: new technologies translate mechanisms to cure (Q26825227) (← links)
- Treatment of primary FSGS in adults (Q26828859) (← links)
- Hypertension and chronic kidney disease: controversies in pathogenesis and treatment (Q26851271) (← links)
- Podocyte pathology and nephropathy - sphingolipids in glomerular diseases (Q26852463) (← links)
- Clinical perspectives on lupus genetics: advances and opportunities (Q27001690) (← links)
- HIV and chronic kidney disease (Q27010688) (← links)
- Addressing the global burden of chronic kidney disease through clinical and translational research (Q27014158) (← links)
- APOL1 and nephropathy progression in populations of African ancestry (Q27022275) (← links)
- APOL1 kidney risk alleles: population genetics and disease associations (Q27024261) (← links)
- Update on current management of chronic kidney disease in patients with HIV infection (Q27691460) (← links)
- Drug-induced glomerular disease: direct cellular injury (Q27692666) (← links)
- The African diaspora: history, adaptation and health (Q28075805) (← links)
- APOL1 toxin, innate immunity, and kidney injury (Q28085667) (← links)
- Population ancestry and genetic risk for diabetes and kidney, cardiovascular, and bone disease: modifiable environmental factors may produce the cures (Q28391758) (← links)
- In vivo Modeling Implicates APOL1 in Nephropathy: Evidence for Dominant Negative Effects and Epistasis under Anemic Stress (Q28546164) (← links)
- A review of the Institute of Medicine's analysis of using chimpanzees in biomedical research (Q28659265) (← links)
- Animal models and conserved processes (Q28710144) (← links)
- What Do We Know about Opioids and the Kidney? (Q30238812) (← links)
- Insights into kidney diseases from genome-wide association studies (Q30248678) (← links)
- Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices (Q30250098) (← links)
- Social Determinants of Racial Disparities in CKD. (Q30250319) (← links)
- Combined Effects of GSTM1 Null Allele and APOL1 Renal Risk Alleles in CKD Progression in the African American Study of Kidney Disease and Hypertension Trial (Q30277219) (← links)
- Association Analysis of the Cubilin (CUBN) and Megalin (LRP2) Genes with ESRD in African Americans. (Q30352406) (← links)
- Lack of Association of the APOL1 G3 Haplotype in African Americans with ESRD (Q30359344) (← links)
- Getting to 90-90-90 in paediatric HIV: What is needed? (Q30385352) (← links)
- APOL1 variants in HIV-associated nephropathy: just one piece of the puzzle (Q33353901) (← links)
- Advances in the pathogenesis of HIV-associated kidney diseases (Q33415306) (← links)
- Evolution of the primate trypanolytic factor APOL1 (Q33665446) (← links)
- Collapsing glomerulopathy, the Saudi Arabian scenario. A study of 31 cases and a review of literature (Q33735329) (← links)
- Personalized Medicine: New Perspectives for the Diagnosis and the Treatment of Renal Diseases (Q33838866) (← links)
- APOL1 renal risk variants have contrasting resistance and susceptibility associations with African trypanosomiasis (Q33866444) (← links)
- Explaining the racial difference in AKI incidence (Q33974656) (← links)
- APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability (Q34001289) (← links)
- Coding variants in nephrin (NPHS1) and susceptibility to nephropathy in African Americans (Q34008876) (← links)
- Research capacity. Enabling the genomic revolution in Africa (Q34068017) (← links)
- Glomerular hypertrophy in subjects with low nephron number: contributions of sex, body size and race. (Q34094361) (← links)
- Effect of race and genetics on vitamin D metabolism, bone and vascular health (Q34280570) (← links)
- Familial clustering of ESRD in the Norwegian population (Q34292853) (← links)
- The New Epidemiology of HIV-Related Kidney Disease (Q34307868) (← links)
- Metabolism, energetics, and lipid biology in the podocyte - cellular cholesterol-mediated glomerular injury. (Q34336370) (← links)
- APOL1 risk variants, race, and progression of chronic kidney disease (Q34383679) (← links)